Silence Therapeut…
USUSDSilence Therapeutics PLC (US:SLNCF) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om virksomheden
- Websted
- silence-therapeutics.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- LONDON, United Kingdom
- Administrerende direktør
- Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
- Ansatte
- 88
- Udestående aktier
- 141.74 mio. pr. 2026-07-31
- Free float
- 37.84 mio.
- Markedsværdi
- 665.67 mio. USD
- Insidere
- 7.97%
- Institutionelle investorer
- 39.68%
- Branche (SIC)
- Pharmaceutical Preparations
Beskrivelse
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Børser og tickere
| Børs | Ticker | Valuta | Pris | Type |
|---|---|---|---|---|
| US USA Stocks | SLNCF | USD | 4 +0.00% | almindelige aktier |
Udbytte
Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Siren, L.L.C. | 5.5% | 3.31 mio. | 2026-06-30 |
| TCG Crossover Management… | 5.04% | 3.03 mio. | 2026-06-30 |
| Redmile Group, LLC | 3.6% | 2.16 mio. | 2026-06-30 |
| Nantahala Capital Manage… | 2.24% | 1.35 mio. | 2026-06-30 |
| Citadel Advisors Llc | 2.21% | 1.33 mio. | 2026-06-30 |
| Nextech Invest, Ltd. | 1.58% | 952 400 | 2026-06-30 |
| Millennium Management Ll… | 1.51% | 909 279 | 2026-06-30 |
| Ikarian Capital, LLC | 1.38% | 830 784 | 2026-06-30 |
| Tetragon Partners GP Ltd… | 1.27% | 764 256 | 2026-06-30 |
| Soleus Capital Managemen… | 1.05% | 630 000 | 2026-06-30 |
| Fidelity Advisor Series… | 0.8% | 482 088 | 2026-07-31 |
| iShares Trust-iShares Bi… | 0.39% | 234 009 | 2026-08-31 |
| ALGER FUNDS-Alger Small… | 0.18% | 105 679 | 2026-07-31 |
| Fidelity Select Portfoli… | 0.17% | 103 912 | 2026-07-31 |
| ALGER INSTITUTIONAL FUND… | 0.07% | 41 292 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 29 538 | 2026-07-31 |
| SPDR INDEX SHARES Fd.S-S… | 0.02% | 9 532 | 2026-06-30 |
| Trust for Professional M… | 0.01% | 8 695 | 2026-05-31 |
| Steward Funds Inc-Stewar… | 0.01% | 5 800 | 2026-07-31 |
| Invesco Exchange-Traded… | 0% | 2 918 | 2026-08-31 |
